Corbus Pharmaceuticals Holdings (CRBP) Change in Acquisitions & Divestments (2021 - 2025)

Corbus Pharmaceuticals Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $37.5 million for Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments rose 59.67% year-over-year to $37.5 million; the TTM figure through Sep 2025 stood at $148.5 million (up 179.01% YoY), while the FY2024 annual figure was $59.5 million, down 14.43% from the prior year.
• Change in Acquisitions & Divestments for Q3 2025 stood at $37.5 million, up from $35.4 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $55.7 million in Q1 2025, with the low at $6.9 million in Q4 2021.
• The 5-year median for Change in Acquisitions & Divestments is $19.1 million (2023), against an average of $23.8 million.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments plunged 61.86% in 2023, then jumped 627.33% in 2025.
• Corbus Pharmaceuticals Holdings' Change in Acquisitions & Divestments stood at $6.9 million in 2021, then surged by 36.77% to $9.4 million in 2022, then surged by 46.18% to $13.7 million in 2023, then soared by 45.59% to $20.0 million in 2024, then surged by 87.67% to $37.5 million in 2025.
• Business Quant data shows CRBP's Change in Acquisitions & Divestments at $37.5 million in Q3 2025, $35.4 million in Q2 2025, and $55.7 million in Q1 2025.